Next Biomedical Co.,Ltd. (KOSDAQ:389650)

Next Biomedical Revenue

Next Biomedical had revenue of 4.12B KRW in the quarter ending March 31, 2026, with 9.22% growth. This brings the company's revenue in the last twelve months to 16.82B, up 53.72% year-over-year. In the year 2025, Next Biomedical had annual revenue of 16.48B with 72.67% growth.

• Revenue (ttm): 16.82B
• Revenue Growth: +53.72%
• P/S Ratio: 19.14
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 321.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	16.48B	6.93B	72.67%
Dec 31, 2024	9.54B	4.66B	95.46%
Dec 31, 2023	4.88B	2.09B	74.67%
Dec 31, 2022	2.80B	527.74M	23.28%
Dec 31, 2021	2.27B	6.63M	0.29%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error